G Model
CRAS2C-3664; No. of Pages 7
U.P. Singh et al. / C. R. Chimie xxx (2013) xxx–xxx
5
Table 7
3.1.1.1. 6-(2-Nitrophenyl)-4-phenyl-6H-1,3-thiazin-2-
amine (A). Yellow crystals; mp: 162–164 8C; Rf: 0.45;
FT-IR (
max; cmꢀ1 KBr): 3356 (NH), 1687 (C-N), 1656–
1645 (aromatic C = N), 1596 (C = C), 1520, 1355 (Ar-NO2),
877, 754; 1H-NMR (400 MHz, CDCl3-d6, TMS)
ppm:
Docking interaction of ligand (D) in complex with IspE kinase.
˚
Hydrogen Bond (Distance in A)
n
Compound
D
A:GLY90:HN – D.mol:O16 (2.46)
A:ALA91:HN – D.mol:O16 (2.46)
A:GLY92:HN – D.mol:O16 (2.05)
A:GLY95:HN – D.mol:O15 (2.18)
D.mol:H26 – A:ILE127:O (2.03)
d
5.63 (s, 1H, H5), 7.33–7.30 (m, 3H), 7.66 (d, 1H, J = 7.9 Ar-
H), 8.35 (d, 1H, J = 7.1 Ar-H), 5.52 (bs, 1H); 13C NMR
(100 MHz, CDCl3)
d ppm: 26.8 (CH), 112.7 (CH), 120.9
(CH), 127.3 (CH), 128.1 (CH), 128.9 (CH), 135.2 (CH),
143.5 (C), 148.0 (C), 162.7 (C); Anal. Calcd. For
bonds were originated from the oxygen of NO2 present on
the phenyl ring with Gly90, Ala91, Gly92, Gly95 (O. . .H)
(Table 7). The remaining H-bond was established in
between hydrogen of by NH2 and oxygen of Ile127
(H. . .O). This finding was suggesting that our molecules
acted as a potent inhibitor of Gram-negative bacteria via
inhibition of IspE kinase.
C16H13N3O2S: C, 61.72; H 4.21; N, 13.50. Found: C,
61.68; H, 4.20; N, 13.54.
3.1.1.2. 6-(2-Nitrophenyl)-4-(4-nitrophenyl)-6H-1,3-thia-
zin-2-amine (B). Dark brown crystals; mp: 168–170 8C; Rf:
0.65; FT-IR (
(C = C), 1658 (aromatic C = N), 1526, 1358 (Ar-NO2), 876,
756; 1H-NMR (400 MHz, CDCl3-d6, TMS)
ppm: 5.68 (s,
1H, H5) 7.43–7.40 (m, 3H), 7.69 (d, 1H, J = 7.8 Ar-H), 8.06 (d,
1H, J = 7.1 Ar-H), 5.56 (bs, 1H); 13C NMR (100 MHz, CDCl3)
n
max; cmꢀ1 KBr): 3360 (NH), 1683 (C-N), 1597
d
3. Experimental
d
ppm: 27.0 (CH), 112.8 (CH), 121.2 (CH), 127.6 (CH), 129.0
(CH), 135.4 (CH), 143.7 (C), 143.9 (C), 148.3 (C), 162.8 (C);
Anal. Calcd. For C16H12N4O4S: C, 53.93; H 3.39; N, 15.72.
Found: C, 53.95; H, 3.42; N, 15.72.
3.1. Analytical methods
Melting points of synthesized compounds were deter-
mined in open capillary tubes in a Hicon melting point
apparatus and are uncorrected. Thin layer chromatograph-
ic analysis was done to monitor the completion of reaction
as well as for identification and characterization of
compounds. The different mobile phases were selected
according to the assumed polarity of the products. The
spots were visualized by exposure to iodine vapor and UV
light. The structures of the compounds were established on
the basis of spectral (FT-IR, 1H-NMR) and elemental
analysis. FT-IR (in 2.0 cmꢀ1, flat, smooth, abex, KBr) spectra
were recorded on Biored FTs spectrophotometer. 1H-NMR
spectra were recorded on Bruker Avance II 400 and
300 MHz NMR spectrometer in CDCl3-d6 and DMSO using
tetramethylsilane (TMS) as internal standard. 13C NMR
spectra were recorded on Bruker Avance II 300 NMR
Spectrometer. Chemical shifts are reported in parts per
3.1.1.3. 4-(2-Amino-6-(2-nitrophenyl)-6H-1,3-thiazin-4-
yl)phenol (C). Brownish crystals; mp: 175–178 8C; Rf:
0.54; FT-IR (
1610 (C = C), 1646–1635 (aromatic C = N), 1519, 1348 (Ar-
NO2), 889, 778; 1H-NMR (400 MHz, CDCl3-d6, TMS)
ppm:
n
max; cmꢀ1 KBr): 3359 (NH), 1680 (C-N),
d
5.46 (s, 1H, H5) 7.37–7.67 (m, 3H), 7.69 (d, 1H, J = 7.6 Ar-
H), 8.06 (d, 1H, J = 7.1, Ar-H), 5.45 (bs, 1H); 13C
NMR (100 MHz, CDCl3)
d ppm: 26.4 (CH), 112.2 (CH),
120.7 (CH), 127.0 (CH), 128.4 (CH), 134.7 (CH), 143.1 (C),
143.4 (C), 148.0 (C), 162.1 (C); Anal. Calcd. For
C
16H13N3O3S: C, 58.70; H 4.00; N, 12.84. Found: C,
57.50; H, 4.10; N, 12.80.
3.1.1.4. 6-(2-Chlorophenyl)-4-(4-nitrophenyl)-6H-1,3-thia-
zin-2-amine (D). Pale yellow crystals; mp: 183–184 8C; Rf:
million (ppm,
(doublet),
d
) and signal are described as s (singlet), d
0.65; FT-IR (
(C = C), 1648–1630 (aromatic C = N), 1529, 1348 (Ar-NO2),
890, 772; 1H-NMR (400 MHz, CDCl3-d6, TMS)
ppm: 5.73
n
max; cmꢀ1 KBr): 3360 (NH), 1680 (C-N), 1638
t
(triplet), (quartet) and (multiplet).
q
m
Elemental analysis was carried out on a Vario EL III CHNOS
elemental analyzer.
d
(s, 1H, H5) 7.31–7.38 (m, 3H), 7.62 (d, 1H, J = 7.9 Ar-H), 8.09
(d, 1H, J = 7.2 Ar-H), 5.45 (bs, 1H); 13C NMR (100 MHz,
3.1.1. General procedure for synthesis of 1,3-thiazine
derivatives
CDCl3) d ppm: 27.6 (CH), 113.5 (CH), 121.7 (CH), 128.0
(CH), 129.6 (CH), 135.9 (CH), 144.3 (C), 144.6 (C), 148.9 (C),
163.1 (C); Anal. Calcd. For C16H12ClN3O2S: C, 55.57; H 3.50;
N, 12.15. Found: C, 55.60; H, 3.60; N, 12.10.
Substituted acetophenone (1 mmol), aromatic alde-
hydes (1 mmol) and thiourea (1 mmol) in PEG-400 were
mixed. To this, CAN (ceric ammonium nitrate) was
added and reaction mixture was stirred at 45 8C. The
progress and completion of reaction mixture was
monitored by TLC. After completion of reaction the
reaction mixture was cooled in dry ice-acetone bath to
precipitate the PEG-400 and extracted with ether (PEG
being insoluble in ether). Ether layer was decanted, dried
and concentrated under reduced pressure. The recovered
PEG-400 can be reused for consecutive runs. The
structures of all the products were ascertained on the
basis of their spectral (IR, 1H-NMR, 13C NMR) and
elemental analysis.
3.1.1.5. 4-(4-Chlorophenyl)-6-(4-nitrophenyl)-6H-1,3-thia-
zin-2-amine (E). Brown crystals; mp: 188–191 8C; Rf: 0.58;
FT-IR (
(C = C), 1650–1633 (aromatic C = N), 1535, 1350 (Ar-NO2),
880, 782; 1H-NMR (400 MHz, CDCl3-d6, TMS)
ppm: 5.52
n
max; cmꢀ1 KBr): 3362 (NH), 1690 (C-N), 1634
d
(s, 1H, H5) 7.35–7.36 (m, 3H), 7.56 (d, 1H, J = 7.6 Ar-H), 8.06
(d, 1H, J = 7.3, Ar-H), 5.56 (bs, 1H); 13C NMR (100 MHz,
CDCl3)
d ppm: 27.2 (CH), 113.0 (CH), 121.5 (CH), 127.9
(CH), 129.2 (CH), 135.6 (CH), 143.8 (C), 144.1 (C), 148.5 (C),
162.9 (C); Anal. Calcd. For C16H12ClN3O2S: C, 55.57; H 3.50;
N, 12.15. Found: C, 55.57; H, 3.52; N, 12.13.
Please cite this article in press as: Singh UP, et al. Ceric ammonium nitrate (CAN) catalysed expeditious one-pot
synthesis of 1,3-thiazine as IspE kinase inhibitor of Gram-negative bacteria using polyethylene glycol (PEG-400) as an